Nectar Lifesciences Limited (NECLIFE.NS) NSE

21.14

-1.11(-4.99%)

Updated at December 24 03:28PM

Currency In INR

Valuation

Market Cap5.4B
Enterprise Value11.03B
P/E Ratio-1.31
PEG Ratio0.01
Price/Sales Ratio0.41
Price/Book Ratio0.66
Enterprise/Revenue0.79
Enterprise/EBITDA-5.43

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.31
Operating Margin-0.19

Management Effectiveness

Return On Assets-0.2
Return On Equity-0.39

Income Statement

Revenue16.7B
Revenue/Share52.15
Gross Profit3.02B
EBITDA-245.66M
Net Income-1.14B
Diluted EPS-5.07

Balance Sheet

Total Cash139.72M
Total Cash/Share0.29
Total Debt4.59B
Total Debt/Equity0.64
Current Ratio0.36
Book Value Per Share31.97

Price History

52-Week Change-47.33
52-Week High41.35
52-Week Low13.05
Moving Average 50 Days16.54
Moving Average 200 Days18.94

Statistics

Average Volume2.47M
Shares Outstanding224.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor10:1
Last Split DateNovember 12, 2008